OptimizeRx Corporation
OPRXNASDAQHealthcareHealth Information Services
As of Oct 16, 2026 close
- Market cap
- $166.25M
- P/E (TTM)
- 36.13
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $4.54$22.25
- Volume (live)
- -
- Avg. volume (3M)
- 156.41K
OptimizeRx (OPRX) Stock Price & Financial Analysis
OptimizeRx Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $8.50 - $8.99 |
|---|---|
| 52-Week High | $22.25 |
| 52-Week Low | $4.54 |
| Open | $8.89 |
| Volume (last close) | 101.46K |
| Average Volume (3M) | 156.41K |
| Revenue (TTM) | 98.65M |
|---|---|
| Net Income (TTM) | 4.60M |
| Free Cash Flow (TTM) | 18.36M |
| EPS (TTM) | $0.24 |
| Profit Margin | 4.66% |
| Operating Margin | 11.45% |
| Return on Equity (ROE) | 3.51% |
| Debt to Equity | 0.15 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Payout Ratio | 0.00% |
| Market Cap | 166.25M |
|---|---|
| Shares Outstanding | 18.79M |
| P/E Ratio (TTM) | 36.13 |
| Price to Sales (P/S) | 1.69 |
| Price to Book (P/B) | 1.27 |
| EV/EBITDA | 10.36 |
| 50-Day MA | $7.86 |
|---|---|
| 200-Day MA | $7.53 |
| 1-Year Change | −54.73% |
Source: Market prices and company fundamentals. Data as of Oct 16, 2026. Data sources and methodology
OptimizeRx at a Glance
As of the Oct 16, 2026 close, OptimizeRx (OPRX) has a market capitalization of $166.25M. The stock trades at 36.1× trailing earnings and 1.7× sales. Over the trailing twelve months it earned $4.60M on revenue of $98.65M (a 4.7% profit margin) and generated $18.36M of free cash flow. Revenue fell 5.8% year over year.
As of its latest reported balance sheet, it holds $24.10M in cash and securities against $19.48M of debt, a net cash position of $4.62M.
OptimizeRx does not currently pay a dividend.
The share price is down 54.7% over the past year. At $8.51 (the Oct 16, 2026 close) it sits within its 52-week range of $4.54 to $22.25, above its 200-day moving average of $7.53.
Based on 6 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $13.00, 52.8% above the Oct 16, 2026 close.
Frequently Asked Questions About OptimizeRx
What is the current stock price for OPRX?
As of the Oct 16, 2026 close, OPRX stock trades at $8.51. The 52-week range is $4.54–$22.25, with a day range of $8.50–$8.99.
What is the P/E ratio for OPRX?
As of the Oct 16, 2026 close, OptimizeRx's trailing twelve-month (TTM) P/E ratio is 36.1, meaning investors pay $36.1 for every $1 of annual earnings. OptimizeRx operates in the Healthcare sector.
Does OPRX pay dividends?
OptimizeRx does not currently pay a regular dividend. The company retains its earnings to reinvest in the business. Check the Dividends tab for historical dividend information.
What do analysts recommend for OPRX?
Based on ratings from 6 professional analysts over the last 90 days, the consensus for OPRX is Buy. The average 12-month price target is $13.00, a 52.8% upside from the Oct 16, 2026 close of $8.51.
What is the market cap of OPRX?
As of the Oct 16, 2026 close, OptimizeRx's market capitalization is $159.9M, classifying it as a micro-cap company. OptimizeRx operates in the Healthcare sector within the Health Information Services industry.